Welcome to the CEBM Glossary. This is not a comprehensive glossary but it outlines some of the key terms that should be understood in relation to Evidence-Based practice. Absolute risk contain detailed given disease or determination and reduction information about other outcome. to its findings. (ARR): The the individual The main feature Diagnostic Test: difference in the patients. This of cohort study is Any medical test event rate includes observation of performed to between control demographic large numbers confirm, or group (CER) and information (for over a long period determine the treated group example, age, (commonly years) presence of (EER): ARR = CER gender, ethnic with comparison disease in an EER. origin) and of incidence rates individual Bias: Any tendency information on in groups that suspected of to influence the diagnosis, differ in exposure having the results of a trial treatment, levels. disease, usually (or their response to Confidence following the interpretation) treatment, and interval (CI): The report of other than the follow-up after range around a symptoms, or experimental treatment. (NCI studys result based on the intervention. Dictionary) within which we results of other Blinding: A CER: Control event would expect the medical tests. technique used in rate; see event true value to lie. Some examples of research to rate. CIs account for the diagnostic tests eliminate bias by Clinical practice sampling error include performing hiding the guideline: A between the study a chest x-ray to intervention from systematically population and the diagnose the patient, developed wider population pneumonia, and clinician, and/or statement the study is taking skin biopsy other researchers designed to assist supposed to to detect who are health care represent. See p11 cancerous cells. interpreting professionals and Confounding (Harvard Guide to results. patients make variable: A Diagnostic test) Case-control study: decisions about variable which is EER: Experimental The observational appropriate health not the one you event rate; see epidemiologic care for specific are interested in Event rate. study of persons clinical but which may Effectiveness: A with the disease circumstances. affect the results measure of the (or other outcome Cochrane of trial. benefit resulting variable) of collaboration: A Critically appraised from an interest and a worldwide topic (CAT): A intervention for a suitable control association of short summary of given health (comparison, groups who create an article from the problem under reference) group and maintain literature, created usual conditions of of persons without systematic to answer a clinical care for a the disease. The reviews of the specific clinical particular group. relationship of an literature for question. Efficacy: A measure attribute to the specific topic Decision of the benefit disease is areas. analysis: The resulting from an examined by Cohort study: The application of intervention for a comparing the analytic method of explicit, given health diseased and epidemiologic quantitative problem under the nondiseased with study in which methods to ideal conditions of regard to how subsets of a analyse decisions an investigation. frequently the defined population under conditions Event rate: The attribute is can be identified of uncertainty. proportion of present or, if who are, have Diagnosis: The patients in a group quantitative, the been, or in the process of in whom an event levels of the future may be determining is observed.. attribute, in each exposed or not health status and Forrest plot: A of the groups. exposed, or the factors diagrammatic Case-series: A exposed in responsible for representation of group or series of different degrees, producing it; may the results of case reports to a factor or be applied to an individual trials in involving patients factors individual, family, a meta-analysis. who were given hypothesized to group or Funnel plot: A similar treatment. influence the community. The method of Reports of case probability of term applied both graphing the series usually occurrence of a to the process of results of trials in a meta-analysis to for clinical date, sex, have no chance show if the results reasons. occupation, of selection. have been Likelihood national origin, For example, a affected by ratio: The language, scheme publication bias. likelihood that a marital status, whereby units Heterogeneity: In given test result income, and are selected systematic would be expected relationship to purposively reviews, the in a patient with head of would yield a amount of the target disorder household in non-random incompatibility compared to the addition to sample. Again, between trials likelihood that the information on a sample included in the same result would the dwelling obtained by review, whether be expected in a place. taking clinical (ie the patient without Local and current members at studies are that disorder. random sample fixed intervals clinically different) for a positive test survey on a list is a or statistical (ie result = LR+ = Local: Of or non-random the results are sensitivity/(1- belonging to or sample unless different from one specificity) characteristic the list was another). for a negative test of a particular arranged in a Historically result = LR- = (1- locality or random order. Controlled sensitivity)/specifi neighbourhood (OECD) Study: A control city Current: Mechanism-based study recruiting Local and current Occurring in or reasoning: control subject(s) random census belonging to Involves an for whom data Local: Of or the present inference from were collected at a belonging to or time mechanisms to time preceding characteristic Random claims that an that at which the of a particular sample: A intervention data are gathered locality or sample that is produces a on the group neighbourhood arrived at by patient-relevant being studied. Current: selecting outcome. Such Inception cohort Occurring in or sample units reasoning will study: A group of belonging to such that each involve an individuals the present possible unit inferential chain identified for time has a fixed and linking the subsequent study Random determinate intervention (such at an early, sample: A probability of as antiarrhythmic uniform point in sample that is selection. drugs) with a the course of the arrived at by Survey: An clinical outcome specified health selecting investigation in (such as condition, or sample units which mortality). before the such that each information is (Howick) condition possible unit systematically MeSH: Medical develops. has a fixed and collected but in Subject Headings: Incidence: The determinate which the a thesaurus of number of new probability of experimental medical terms cases of illness selection. method is not used by many commencing, or of Census: An used. databases and persons falling ill, enumeration of Local non-random libraries to index during a specified a population, sample and classify time period in a originally Local: Of or medical given population. intended for belonging to or information. Intention-to-treat: purposes of characteristic Monitoring Test: Characteristic of a taxation and of a particular Any medical test study where military locality or performed to patients are service. Census neighbourhood confirm, or analysed in the enumeration of Non-random determine the groups to which a population of sample: A presence of they were a population sample disease in an originally usually records selected by a individual assigned, even identities of all non-random suspected of though they may persons in method, and as having the have switched every place of a result, some disease, usually treatment arms residence, with elements of the following the during the study age, or birth population report of symptoms, or Negative controlled studies. society to prevent based on the predictive value (Howick) disease happening or results of other (-PV): The Odds: A ratio of its consequences. In medical tests. proportion of events to non- general, prevention Some examples of people with a events. If the includes a wide diagnostic tests negative test who event rate for a range of include performing are free of disease is 0.2 interventions, aimed a chest x-ray to disease. (20%), its non- at reducing risks to diagnose Number needed to event rate is 0.8 health. These are pneumonia, and treat (NNT): The and therefore its grouped into three taking skin biopsy number of odds are 2/8. categories: to detect patients who need p value: The Primary cancerous cells. to be treated to probability that a prevention: (Harvard Guide to prevent one bad particular result refers to Diagnostic test) outcome. It is the would have Nested Case- inverse of the happened by strategies control study: A ARR: NNT=1/ARR. chance. used to case control study Numbers needed Positive predictive prevent a in which cases and to harm (NNH)-the value (+PV): The disease controls are drawn number of proportion of happening in from the patients who, if people with a the first population in a they received the positive test who cohort study. As experimental have disease. place. An some data are treatment, would Post-test example may already available lead to one probability: The be salt about both cases additional person probability that a reduction to and controls, the being harmed patient has the prevent an effects of some compared with disorder of interest individual potential patients who after the test becoming confounding receive the control result is known. variables are treatment; Pre-test hypertensive. reduced or calculated as probability: The Medication eliminated. In this 1/ARI. probability that a can be used type of case Observational patient has the in primary control study, a study: A family of disorder of interest prevention set of controls is studies in which prior to such as the selected from investigators administering a subjects, i.e. non- compare people test. use of blood cases, at risk at who take an Post-marketing lowering or the time of intervention with surveillance: A cholesterol occurrence of those who do not. procedure lowering each case that The investigators implemented after drugs to arises in a cohort, neither allocate a drug has been lower the risk thus allowing for patients to receive licensed for public the confounding the intervention use, designed to of a stroke or effect of time in not administer the provide heart attack. the analysis. intervention. information on the Secondary n-of-1 trial: A Instead, they actual use of the prevention: variation of a compare records drug for a given refers to randomized of patients who indication and on strategies controlled trial in had taken an the occurrence of used in those which a sequence intervention and side effects, of alternative been treated in adverse reactions, with an treatment routine practice etc. A method for existing regimens is with similar epidemiologic disease which randomly patients who had study of adverse prevent allocated to a not taken the drug reactions. recurrence, or patient. The intervention. The Prevalence: The significant outcomes of most common baseline risk of a regimens are observational disorder in the morbidity. For compared, with designs are case- population of example, in the aim of studies, case- interest. someone who deciding on the series, case- Prevention: Prevent has a heart optimum regimen control studies, ion refers to attack for the patient. cohort studies, measures taken by cholesterol and historically an individual or a lowering (inconclusive trials disease who have validity of a study drugs are are less likely to a positive test. refers to the be published than Specificity: The appropriateness used to lower conclusive ones, proportion of by which its the risk of but are not people free of a results can be subsequent necessarily less disease who have applied to non- heart attack valid). a negative test. study patients or and death. Randomized trial: Systematic review: populations. Tertiary An epidemiological The application of experiment in strategies that prevention: which subjects in a limit bias in the All definitions in the refers to the population are assembly, critical glossary are from: prevention of randomly appraisal, and Last, J. M. (2001) A Dictionary of Epidemiology long term allocated into synthesis of all Fourth Edition. Oxford chronic groups, usually relevant studies University Press disease called study and on a specific topic. control groups, to Systematic Harvard Health Publication progression, (2010) A Guide to receive or not reviews focus on Diagnostic Tests, viewed physical receive an peer-reviewed 23 November 2010 deterioration experimental publications about http://www.health.harvard. and preventive or a specific health edu/diagnostic-tests-and- medical-procedures attendant therapeutic problem and use suffering. For procedure, rigorous, Howick, J. example, maneuver, or standardized (Forthcoming) Resolving intervention. The methods for the paradoxes in removing Evidence-Based Medicine. results are selecting and A philosophical allergens assessed by assessing articles. inquiry. Blackwell/Wiley which may rigorous A systematic aggravate comparison of review may or Organisation for Economic Co-operation and asthmatic rates of disease, may not include Development (OECD) patients; death, recovery, a meta-analysis, (2010) Glossary of or other which is a Statistical Terms, viewed screening for 25 November 2010 appropriate quantitative eye, renal, outcome in the summary of the http://stats.oecd.org/glossa ry/ eye, and foot study and control results. National Cancer Institute problems groups. Treatment (NCI) (2010) NCI Relative risk (RR) benefits: Positive Dictionary of Cancer among Term, viewed 23 diabetics to (or risk patient-relevant November 2010 reduce the ratio): The ratio outcome http://www.cancer.gov/dicti of the risk of an associated with an onary/?CdrID=44006 risks of event in the intervention, complications experimental quantifiable by . group compared epidemiological Prognosis: The to that of the measures such as prospect of control group absolute risk survival and (RR=EER / CER). reduction (ARR) recovery from a Not to be confused and number disease as with relative risk needed to treat anticipated from reduction (see (NNT). the usual course below). Validity: The extent of that disease or Relative risk to which a variable indicated by reduction or intervention special features of (RRR): The measures what it the case. percentage is supposed to Prognostic cohort reduction in measure or study: events in the accomplishes Publication bias: A treated group what it is bias in a event rate (EER) supposed to systematic review compared to the accomplish. caused by control group The internal incompleteness of event rate (CER): validity of a study the search, such RRR = (CER-EER) / refers to the as omitting non- CER. integrity of the English language Sensitivity: The experimental sources, or proportion of design. unpublished trials people with The external